首页|PLR-HRR评分在胃癌术后患者预后中的应用价值

PLR-HRR评分在胃癌术后患者预后中的应用价值

扫码查看
目的 探究血小板/淋巴细胞比值(PLR)与血红蛋白/红细胞分布宽度比值(HRR)联合构成的PLR-HRR评分对胃癌完整切除(R0)术后患者生存的预测价值.方法 回顾性收集 2019年 1 月 1 日至 2020 年 6 月30 日在宁夏医科大学总医院行胃癌R0 术后辅助化疗的 146 例胃癌患者的临床病理资料,应用ROC曲线确定PLR和HRR最佳截断值进行分组并建立PLR-HRR评分,分析不同PLR-HRR评分与胃癌患者临床病理特征的关系,采用Kaplan-Meier生存曲线和COX风险回归分析评估PLR-HRR评分在胃癌R0 术后患者预后中的应用价值.建立基于PLR-HRR评分的生存率预后模型,计算模型C指数;绘制ROC曲线评估模型区分度;绘制决策分析曲线(DCA)和临床影响曲线(CIC)评估列线图模型的临床疗效.结果 PLR、HRR预测胃癌患者生存率的最佳截断值分别为 186.09 和 9.85.将患者分为 3组,PLR-HRR 0 分组 40 例(PLR<186.09且HRR≥9.85);PLR-HRR 1 分组 73 例(PLR≥186.09 且HRR≥9.85、PLR<186.09 且HRR<9.85);PLR-HRR 2 分组 33 例(PLR≥186.09 且HRR<9.85).不同PLR-HRR评分组肿瘤最大径、TNM分期、PLR、HRR差异均有统计学意义(P均<0.05).Kaplan-Meier生存曲线结果显示,PLR-HRR评分 0 分、1 分、2 分组 3 年生存率分别为 84.0%、61.5%、14.6%,差异有统计学意义(P<0.001).多因素COX回归分析显示,有腹腔积液、肿瘤最大径≥5 cm、TNM分期为Ⅳ期、PLR-HRR评分为 2 分是影响胃癌R0 术后患者生存的影响因素(P均<0.05).基于PLR-HRR及其他影响因素构建的列线图C指数为0.767(95%CI:0.711~0.823),ROC曲线显示预测模型区分度良好,DCA和CIC曲线显示预测模型在大部分阈值概率范围内提供了显著的净收益.结论 PLR-HRR评分可作为评估胃癌R0 术后患者预后的可靠指标,评分越高提示患者预后越差.基于PLR-HRR及其他影响因素构建的列线图具有良好的预测能力.
Prognostic Value of PLR-HRR Score in Postoperative Patients with Gastric Cancer
Objective To investigate the predictive value of the PLR-HRR score,which consists of the combination of absolute platelet/lymphocyte ratio(PLR)and hemoglobin/red cell distribution width ratio(HRR),on the survival of patients after R0 resection for gastric cancer.Methods The clinicopathological data of 146 gastric cancer patients who underwent adjuvant chemotherapy after R0 resection of gastric cancer in the General Hospital of Ningxia Medical University from January 1,2019 to June 30,2020 were retrospectively collected.The optimal cut-off values of PLR and HRR were determined by applying ROC curves for grouping and establishment of PLR-HRR scores.The correlation between different PLR-HRR scores and clinicopathological characteristics of gastric cancer patients were compared.The Kaplan-Meier survival curve and COX risk regression were used to assess the application value of the PLR-HRR score in the prognosis of patients with gastric cancer after R0 resection of gastric cancer.A survival rate prognosis model based on PLR-HRR score was established,and the C-index of the model was calculated.The ROC curve was drawn to evaluate the model discrimination,and the decision analysis curve(DCA)and clinical impact curve(CIC)were drawn to evaluate the clinical efficacy of the nomogram model.Results The optimal cut-off values of PLR and HRR for predicting the survival rate of gastric cancer patients were 186.09 and 9.85 respectively.The patients were divided into three groups:40 patients in the PLR-HRR 0 group(PLR<186.09 and HRR≥9.85);73 patients in the PLR-HRR 1 group(PLR≥186.09 and HRR≥9.85 or PLR<186.09 and HRR<9.85);33 patients in the PLR-HRR 2 group(PLR≥186.09 and HRR<9.85).PLR-HRR score was correlated with tumor maximum diameter,TNM stage,PLR,and HRR(P all<0.05).The results of Kaplan-Meier survival curve showed that the 3-year survival rates of PLR-HRR score of 0,1 and 2 were 84.0%,61.5%and 14.6%respectively,and the difference was statistically significant(P<0.001).Multifactorial COX regression analysis showed that ascites,maximum tumor diameter≥5 cm,TNM stageⅣ,and PLR-HRR score 2 were influencing factors affecting the survival of patients after R0 resection for gastric cancer(P all<0.05).The C-index of the Nomogram constructed based on PLR-HRR and other influencing factors was C-index=0.767(95%CI:0.711-0.823).The ROC curve showed good model differentiation,and the DCA and CIC curves showed that the predictive model provided significant benefits over most of the threshold probability range.Conclusion The PLR-HRR score can be used as a reliable index to assess the prognosis of patients after R0 resection for gastric cancer,with higher scores suggesting a worse prognosis for patients.The Nomogram constructed based on PLR-HRR and other influencing factors has good predictive ability.

gastric cancerplatelet/lymphocyte ratiohemoglobin/red cell distribution width ratio

苏利君、肖雯、苗亚萍、罗娜、樊维宁、陈萍

展开 >

宁夏医科大学第一临床医学院,银川 750004

宁夏医科大学总医院肿瘤内二科,宁夏医科大学第一临床医学院,银川 750004

胃癌 血小板/淋巴细胞比值 血红蛋白/红细胞分布宽度比值

2024

宁夏医科大学学报
宁夏医科大学

宁夏医科大学学报

CSTPCD
影响因子:0.84
ISSN:1674-6309
年,卷(期):2024.46(6)